Larry W. Hardy

2.1k total citations
36 papers, 1.7k citations indexed

About

Larry W. Hardy is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Materials Chemistry. According to data from OpenAlex, Larry W. Hardy has authored 36 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 7 papers in Materials Chemistry. Recurrent topics in Larry W. Hardy's work include Biochemical and Molecular Research (9 papers), Neuroscience and Neuropharmacology Research (8 papers) and Enzyme Structure and Function (7 papers). Larry W. Hardy is often cited by papers focused on Biochemical and Molecular Research (9 papers), Neuroscience and Neuropharmacology Research (8 papers) and Enzyme Structure and Function (7 papers). Larry W. Hardy collaborates with scholars based in United States, United Kingdom and Germany. Larry W. Hardy's co-authors include Stephen M. Beverley, Bakela Nare, W.R. Montfort, Janet Finer-Moore, Robert M. Stroud, Daniel V. Santi, Jack F. Kirsch, James Luba, Frank Maley and Gladys F. Maley and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Larry W. Hardy

36 papers receiving 1.7k citations

Peers

Larry W. Hardy
James R. Appleman United States
H. Eibl Germany
John G. Menting Australia
Claudia Kent United States
Timothy E. Benson United States
Robert T. Jacobs United States
James R. Appleman United States
Larry W. Hardy
Citations per year, relative to Larry W. Hardy Larry W. Hardy (= 1×) peers James R. Appleman

Countries citing papers authored by Larry W. Hardy

Since Specialization
Citations

This map shows the geographic impact of Larry W. Hardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry W. Hardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry W. Hardy more than expected).

Fields of papers citing papers by Larry W. Hardy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry W. Hardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry W. Hardy. The network helps show where Larry W. Hardy may publish in the future.

Co-authorship network of co-authors of Larry W. Hardy

This figure shows the co-authorship network connecting the top 25 collaborators of Larry W. Hardy. A scholar is included among the top collaborators of Larry W. Hardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry W. Hardy. Larry W. Hardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schreiber, Rudy, Una C. Campbell, Maria S. Quinton, et al.. (2022). In vitro and in vivo pharmacological characterization of dasotraline, a dual dopamine and norepinephrine transporter inhibitor in vivo. Biomedicine & Pharmacotherapy. 153. 113359–113359. 7 indexed citations
2.
Hardy, Larry W., Jenna M. Sullivan, Noel A. Powell, et al.. (2020). Functional deficit in hippocampal activity during fear extinction recall in the single prolonged-stress model of PTSD in male rats. Behavioural Brain Research. 396. 112902–112902. 5 indexed citations
3.
Sramek, John J., Larry W. Hardy, P. R. Bieck, et al.. (2016). Exploratory Biomarker Study of the Triple Reuptake Inhibitor SEP‐432 Compared to the Dual Reuptake Inhibitor Duloxetine in Healthy Normal Subjects. CNS Neuroscience & Therapeutics. 22(5). 404–412. 3 indexed citations
4.
Shao, Liming, Michael C. Hewitt, Fengjiang Wang, et al.. (2011). Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor. Bioorganic & Medicinal Chemistry Letters. 21(5). 1438–1441. 7 indexed citations
5.
Shao, Liming, Fengjiang Wang, Jianguo Ma, et al.. (2010). Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors. Bioorganic & Medicinal Chemistry. 19(1). 663–676. 16 indexed citations
6.
Shao, Liming, Jianguo Ma, Fengjiang Wang, et al.. (2010). Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor. Bioorganic & Medicinal Chemistry Letters. 21(1). 520–523. 3 indexed citations
7.
Schüttelkopf, Alexander W., Larry W. Hardy, Stephen M. Beverley, & William N. Hunter. (2005). Structures of Leishmania major Pteridine Reductase Complexes Reveal the Active Site Features Important for Ligand Binding and to Guide Inhibitor Design. Journal of Molecular Biology. 352(1). 105–116. 65 indexed citations
8.
Saraswat, Lakshmi D., et al.. (2005). Affinity Ligand Selection from a Library of Small Molecules: Assay Development, Screening, and Application. Biotechnology Progress. 21(1). 300–308. 6 indexed citations
9.
Hardy, Larry W. & Norton P. Peet. (2004). The multiple orthogonal tools approach to define molecular causation in the validation of druggable targets. Drug Discovery Today. 9(3). 117–126. 33 indexed citations
10.
Gourley, David G., James Luba, Larry W. Hardy, Stephen M. Beverley, & William N. Hunter. (1999). Crystallization of recombinant Leishmania major pteridine reductase 1 (PTR1). Acta Crystallographica Section D Biological Crystallography. 55(9). 1608–1610. 18 indexed citations
11.
Poteete, Anthony R., Dale Rennell, Suzanne E. Bouvier, & Larry W. Hardy. (1997). Alteration of T4 lysozyme structure by second‐site reversion of deleterious mutations. Protein Science. 6(11). 2418–2425. 19 indexed citations
12.
Nare, Bakela, Larry W. Hardy, & Stephen M. Beverley. (1997). The Roles of Pteridine Reductase 1 and Dihydrofolate Reductase-Thymidylate Synthase in Pteridine Metabolism in the Protozoan Parasite Leishmania major. Journal of Biological Chemistry. 272(21). 13883–13891. 159 indexed citations
13.
Nare, Bakela, James Luba, Larry W. Hardy, & Stephen M. Beverley. (1997). New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity. Parasitology. 114(7). 101–110. 112 indexed citations
14.
Hardy, Larry W. & Anthony R. Poteete. (1991). Reexamination of the role of Asp20 in catalysis by bacteriophage T4 lysozyme. Biochemistry. 30(39). 9457–9463. 49 indexed citations
15.
Torgerson, Rochelle R., et al.. (1991). Highly restricted distributions of hydrophobic and charged amino acids in longitudinal quadrants of alpha-helices.. Journal of Biological Chemistry. 266(9). 5521–5524. 17 indexed citations
16.
Montfort, W.R., Kathy M. Perry, Eric B. Fauman, et al.. (1990). Structure, multiple site binding, and segmental accommodation in thymidylate synthase on binding dUMP and an anti-folate. Biochemistry. 29(30). 6964–6977. 202 indexed citations
17.
Hardy, Larry W. & Jack F. Kirsch. (1989). Isolation of a Staphylococcus aureus β-lactamase-dicloxacillin complex and kinetic studies on the reactivation of the enzyme. Archives of Biochemistry and Biophysics. 268(1). 338–348. 6 indexed citations
18.
Hardy, Larry W. & Jack F. Kirsch. (1984). Diffusion-limited component of reactions catalyzed by Bacillus cereus .beta.-lactamase I. Biochemistry. 23(6). 1275–1282. 65 indexed citations
20.
Hardy, Larry W. & Jack F. Kirsch. (1984). pH Dependence and solvent deuterium oxide kinetic isotope effects on Bacillus cereus .beta.-lactamase I catalyzed reactions. Biochemistry. 23(6). 1282–1287. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026